Market reports on India presents the latest report on “Indian Market Report for Anti-Adhesion Products”. There are a number of different methods that surgeons use to reduce the incidence of adhesions.
The anti-adhesion market, also referred to as the adhesion prevention market, includes products aimed at minimizing surgical adhesions. Surgical adhesions are fibrous bands that form between tissues and organs, often as a result of injury during surgery. These adhesions can be formed during any type of surgery, including gynecological, abdominal, orthopedic, cardiac and neurological procedures. Adhesions are often thought of as internal scar tissue and are a side effect of the bodys natural healing process. For example, up to 93% of patients who undergo intra-abdominal surgery develop adhesions. The majority of adhesions are asymptomatic; however, approximately 5% of adhesions result in severe symptoms such as pain, small bowel obstruction (SBO), range of motion restriction and/or infertility. While only 5% of adhesions result in symptoms severe enough to require further treatment, as many as 30% are thought to cause low level discomfort that is tolerated by the patient. Adhesions are believed to be responsible for approximately 65% of all SBO, 35% of chronic pelvic pain and 20% of infertility diagnoses.
There are a number of different methods that surgeons use to reduce the incidence of adhesions. The most effective way is to perform laparoscopic procedures whenever possible, as they carry a much lower risk of symptomatic adhesion formation. In addition, surgeons attempt to minimize tissue necrosis, providing meticulous hemostasis, liberally irrigating the abdominal cavity and using non-reactive suture materials. In some situations, drugs that inhibit the inflammatory response, such as corticosteroids, non-steroidal anti-inflammatory, pentoxifylline and calcium channel blockers have been used. However, the most effective method of reducing adhesions has been determined to be the use of adhesion barriers.
The first currently used product entered the market in 1989 and was made out of oxidized regenerated cellulose (ORC). It is absorbed within four weeks of application. Seprafilm by Genzyme consists of sodium hyaluronate and carboxymethylcellulose, forming a film that becomes a hydrated gel 24 to 48 hours after placement.
To read the complete report at:
Related Research Reports: http://www.marketreportsonindia.com/market-research-report/life-sciences.html
Market Reports on India
Contact No: India: +91 22 27810772, 27810773